Suppressing COVID-19 transmission in Hong Kong: an observational study of the first four months

Background: Hong Kong was one of the first locations outside of mainland China to identify COVID-19 cases in January 2020. We assessed the impact of various public health measures on transmission.Methods: We analysed data on all COVID-19 cases and public health measures in Hong Kong up to 7 May 2020. We described case-based, travel-based and community-based measures and examined their potential effects on case identification and transmission. Changes in transmissibility measured by the effective reproductive number Rt were estimated by comparing the Rt between periods when public health measures were and were not in effect. Delays in case confirmation in imported cases and locally infected cases were analysed to indicate the possible impact of expansion of laboratory testing capacity.Findings: Introduction of a 14-day quarantine on persons arriving from affected areas was associated with a 95% reduction in transmissibility from imported cases. Testing all arriving travelers reduced mean delays between arrival and detection of imported cases. Increases in laboratory testing capacity for pneumonia inpatients and symptomatic outpatients reduced the delay from onset to confirmation. Working from home and physical distancing measures implemented in high-risk facilities were associated with 67% and 58% reductions in transmission of COVID-19, respectively.Interpretation: Suppression of COVID-19 transmission in the first pandemic wave in Hong Kong was achieved through integration of travel-based, case-based and community-based public health measures focusing on early case identification and isolation and physical distancing.

[1]  E. Lau,et al.  Clustering and superspreading potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Hong Kong , 2020 .

[2]  Kwok-Hung Chan,et al.  Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial , 2020, The Lancet.

[3]  Hsien-Ho Lin,et al.  Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset , 2020, JAMA internal medicine.

[4]  D. Havlir,et al.  Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19 , 2020, The New England journal of medicine.

[5]  K. To,et al.  The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2 , 2020, Journal of Infection.

[6]  Peng Wu,et al.  Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study , 2020, The Lancet Public Health.

[7]  B. Cowling,et al.  From a Sprint to a Marathon in Hong Kong , 2020, The New England journal of medicine.

[8]  T. Greenhalgh,et al.  Face masks for the public during the covid-19 crisis , 2020, BMJ.

[9]  Tai Hing Lam,et al.  Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity , 2020, The Lancet.

[10]  C. Whittaker,et al.  Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.

[11]  Kai Kupferschmidt,et al.  Countries test tactics in 'war' against COVID-19. , 2020, Science.

[12]  B. Cowling,et al.  Rational use of face masks in the COVID-19 pandemic , 2020, The Lancet Respiratory Medicine.

[13]  G. Wong,et al.  SARS-CoV-2 Infection in Children , 2020, The New England journal of medicine.

[14]  Eric H. Y. Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[15]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[16]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[17]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[18]  Simon Cauchemez,et al.  Reconstruction of antibody dynamics and infection histories to evaluate dengue risk , 2018, Nature.

[19]  J. Giesecke.  Primary and index cases , 2014, The Lancet.

[20]  C. Fraser,et al.  A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics , 2013, American journal of epidemiology.

[21]  B. Cowling,et al.  Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong. , 2010, The Journal of infectious diseases.

[22]  Joshua B. Plotkin,et al.  Reconstructing influenza incidence by deconvolution of daily mortality time series , 2009, Proceedings of the National Academy of Sciences.

[23]  C. Fraser.  Estimating Individual and Household Reproduction Numbers in an Emerging Epidemic , 2007, PloS one.

[24]  A. Hedley,et al.  Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  G. Leung,et al.  A Tale of Two Cities: Community Psychobehavioral Surveillance and Related Impact on Outbreak Control in Hong Kong and Singapore During the Severe Acute Respiratory Syndrome Epidemic , 2004, Infection Control & Hospital Epidemiology.